These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9322286)

  • 21. Cholera vaccine will reduce antibiotic use.
    Okeke IN
    Science; 2009 Aug; 325(5941):674. PubMed ID: 19661401
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vibrio cholerae in Madagascar: study of a multiresistant strain].
    Rakoto Alson AO; Dromigny JA; Pfister P; Mauclère P
    Arch Inst Pasteur Madagascar; 2001; 67(1-2):6-13. PubMed ID: 12471739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vibrio cholerae O1 strains with decreased susceptibility to fluoroquinolones in travellers returning from India (Rajasthan) to France, April 2007.
    Tarantola A; Quilici ML;
    Euro Surveill; 2007 May; 12(5):E070503.2. PubMed ID: 17868606
    [No Abstract]   [Full Text] [Related]  

  • 24. Public health. No vaccines in the time of cholera.
    Enserink M
    Science; 2010 Sep; 329(5998):1462-3. PubMed ID: 20847246
    [No Abstract]   [Full Text] [Related]  

  • 25. Epidemiological surveillance of cholera.
    Epidemiol Bull; 1991; 12(1):12-4. PubMed ID: 2054284
    [No Abstract]   [Full Text] [Related]  

  • 26. Typing and antibiotic susceptibility patterns of Vibrio cholerae during six consecutive cholera seasons in north India.
    Kaur H; Lal M
    Trop Gastroenterol; 1998; 19(2):59-61. PubMed ID: 9752752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing pattern of Vibrio cholerae serotype EL TOR and 0139 in Yavatmal (Maharashtra, India) during 1992 to 1994.
    Ingole KV; Jalgaonkar SV; Fule C; Fule RP
    Indian J Pathol Microbiol; 1997 Jul; 40(3):369-71. PubMed ID: 9354010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consecutive outbreaks of Vibrio cholerae O139 and V. cholerae O1 cholera in a fishing village near Karachi, Pakistan.
    Siddiqui FJ; Bhutto NS; von Seidlein L; Khurram I; Rasool S; Ali M; Zafar A; Deen JL; Clemens JD; Nizami Q; Bhutta ZA
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):476-82. PubMed ID: 16443247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholera, 2014.
    Wkly Epidemiol Rec; 2015 Oct; 90(40):517-28. PubMed ID: 26433979
    [No Abstract]   [Full Text] [Related]  

  • 30. [First cases of cholera observed in children at the Befelatanana General Hospital--Antananarivo University Hospital Center (Madagascar)].
    Raobijaona H; Razafimalala F; Rakotondramarina D; Rakotomalala NJ; Pfister P; Roux JF; Rakotoarimanana RD
    Arch Inst Pasteur Madagascar; 1999; 65(1-2):71-4. PubMed ID: 12478963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endemic cholera in Delhi, 1995: analysis of data from a sentinel centre.
    Singh J; Sachdeva V; Bhatia R; Bora D; Jain DC; Sokhey J
    J Diarrhoeal Dis Res; 1998 Jun; 16(2):66-73. PubMed ID: 9805411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholera in the United States, 1995-2000: trends at the end of the twentieth century.
    Steinberg EB; Greene KD; Bopp CA; Cameron DN; Wells JG; Mintz ED
    J Infect Dis; 2001 Sep; 184(6):799-802. PubMed ID: 11517445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholera situation in the Americas.
    Epidemiol Bull; 1992 Jul; 13(2):13-4. PubMed ID: 1380820
    [No Abstract]   [Full Text] [Related]  

  • 34. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibiotic susceptibility of Vibrio cholerae 01: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon)].
    Guévart E; Solle J; Mouangue A; Noeske J; Bita A; Fonkoua MC; Ndayo Wouafo M
    Med Mal Infect; 2006 Jun; 36(6):329-34. PubMed ID: 16757139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cholera in Tamatave (Madagascar) February-July 2000: epidemiological characteristics].
    Jaureguiberry S; Hentgen V; Raholiniana N; Rasolomahefa D; Belec M
    Sante; 2001; 11(2):73-8. PubMed ID: 11440880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of climate on the disease dynamics of cholera.
    Koelle K
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():29-31. PubMed ID: 19220350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Das SS; Chhotray GP
    Jpn J Infect Dis; 2006 Aug; 59(4):266-9. PubMed ID: 16936349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell.
    Morris JG
    Clin Infect Dis; 2003 Jul; 37(2):272-80. PubMed ID: 12856219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environmental Vibrio cholerae O139 may be the progenitor of outbreak of cholera in coastal area of Orissa, eastern India, 2000: molecular evidence.
    Khuntia HK; Pal BB; Meher PK; Chhotray GP
    Am J Trop Med Hyg; 2008 May; 78(5):819-22. PubMed ID: 18458319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.